| Year |
Citation |
Score |
| 2014 |
Lee H, Lee H, Kudo W. P1-106: ABERRANT ACTIVATION OF PKC-THETA IN ALZHEIMER'S DISEASE AND ITS ROLE IN NEURONAL INSULIN RESISTANCE Alzheimer's & Dementia. 10: P340-P340. DOI: 10.1016/J.Jalz.2014.05.343 |
0.614 |
|
| 2013 |
Kudo W, Petersen RB, Lee HG. Cellular prion protein and Alzheimer disease: link to oligomeric amyloid-β and neuronal cell death. Prion. 7: 114-6. PMID 23154635 DOI: 10.4161/Pri.22848 |
0.672 |
|
| 2012 |
Kudo W, Lee HP, Smith MA, Zhu X, Matsuyama S, Lee HG. Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity. Cell Death & Disease. 3: e309. PMID 22592316 DOI: 10.1038/cddis.2012.43 |
0.648 |
|
| 2012 |
Kudo W, Lee HP, Zou WQ, Wang X, Perry G, Zhu X, Smith MA, Petersen RB, Lee HG. Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death. Human Molecular Genetics. 21: 1138-44. PMID 22100763 DOI: 10.1093/Hmg/Ddr542 |
0.732 |
|
| 2012 |
Kudo W, Lee H, Petersen R, Lee H. O3-04-03: Identification of a signal transduction mechanism of amyloid-β/PrPC
interaction Alzheimer's & Dementia. 8: P435-P435. DOI: 10.1016/J.Jalz.2012.05.1160 |
0.532 |
|
| 2011 |
Lee HP, Kudo W, Zhu X, Smith MA, Lee HG. Early induction of c-Myc is associated with neuronal cell death. Neuroscience Letters. 505: 124-7. PMID 22005580 DOI: 10.1016/J.Neulet.2011.10.004 |
0.734 |
|
| 2011 |
Nair N, Kudo W, Smith MA, Abrol R, Goddard WA, Reddy VP. Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: synthesis, neuronal cell culture investigations, and CDK5 docking studies. Bioorganic & Medicinal Chemistry Letters. 21: 3957-61. PMID 21641213 DOI: 10.1016/J.Bmcl.2011.05.019 |
0.56 |
|
| 2011 |
Bajić VP, Su B, Lee HG, Kudo W, Siedlak SL, Zivković L, Spremo-Potparević B, Djelic N, Milicevic Z, Singh AK, Fahmy LM, Wang X, Smith MA, Zhu X. Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease. Cellular & Molecular Biology Letters. 16: 359-72. PMID 21461981 DOI: 10.2478/S11658-011-0011-2 |
0.742 |
|
| 2011 |
Kudo W, Lee H, Zhu X, Smith M, Lee H. P2-299: Cell cycle aberrations mediate neurotoxicity induced by soluble amyloid-beta oligomers Alzheimer's & Dementia. 7: S406-S406. DOI: 10.1016/J.Jalz.2011.05.1177 |
0.702 |
|
| 2011 |
Nair N, Kudo W, Smith MA, Abrol R, Goddard WA, Reddy VP. Corrigendum to “Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: Synthesis, neuronal cell culture investigations, and CDK5 docking studies” [Bioorg. Med. Chem. Lett. 11 (2001) 3165–3168] Bioorganic & Medicinal Chemistry Letters. 21: 5649. DOI: 10.1016/J.Bmcl.2011.07.014 |
0.583 |
|
| 2010 |
Bonda DJ, Lee HP, Kudo W, Zhu X, Smith MA, Lee HG. Pathological implications of cell cycle re-entry in Alzheimer disease. Expert Reviews in Molecular Medicine. 12: e19. PMID 20584423 DOI: 10.1017/S146239941000150X |
0.731 |
|
| 2010 |
Kudo W, Zhu X, Bajić VP, Lee H, Smith MA. P1-287: Neuronal cell cycle re-entry as a neurotoxic mechanism of soluble amyloid oligomers in hippocampal slice cultures Alzheimer's & Dementia. 6: S257-S257. DOI: 10.1016/J.Jalz.2010.05.839 |
0.716 |
|
| 2010 |
Lee H, Lee H, Kudo W, Zhu X, Perry G, Smith MA. P2-316: Disturbance in AMP-activated protein kinase (AMPK) signaling pathway in Alzheimer's disease Alzheimer's & Dementia. 6: S406-S406. DOI: 10.1016/J.Jalz.2010.05.1367 |
0.69 |
|
| 2009 |
Liu G, Men P, Kudo W, Perry G, Smith MA. Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease. Neuroscience Letters. 455: 187-90. PMID 19429118 DOI: 10.1016/J.Neulet.2009.03.064 |
0.642 |
|
| Show low-probability matches. |
